Search research articles
Contact Us
Filters
Showing results (271-280 of 300) with videos related to
Page
of 30
Sort By:
European Journal of Neurology
|
April 5, 2024
Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group
Michelangelo Mancuso, Maria T Papadopoulou, Yi Shiau Ng, et al.
BMC Cancer
|
June 20, 2020
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
David P French, Susan Astley, Adam R Brentnall, et al.
Trials
|
September 20, 2022
Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy
, Alaa Abouhajar, Lisa Alcock, et al.
Trials
|
October 5, 2022
Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy
, Alaa Abouhajar, Lisa Alcock, et al.
Brain Communications
|
December 5, 2025
Elevated glioma-related cortical glutamate <i>in vivo</i> is associated with <i>ex vivo</i> interictal discharges in human brain slices
Bodiabaduge Ashan P Jayasekera, Jehill Parikh, Tamara Modebadze, et al.
Scientific Reports
|
May 18, 2026
Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial
Renae J Stefanetti, Chiara Pizzamiglio, Alasdair P Blain, et al.
JAMA Neurology
|
April 11, 2017
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy
Ewen W Sommerville, Yi Shiau Ng, Charlotte L Alston, et al.
British Journal of Cancer
|
April 24, 2023
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
D Gareth Evans, Lorna McWilliams, Susan Astley, et al.
British Journal of Cancer
|
April 3, 2023
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
D Gareth Evans, Lorna McWilliams, Susan Astley, et al.
The Journal of Clinical Investigation
|
May 26, 2022
RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis
Jonathan Shintaku, Wolfgang M Pernice, Wafaa Eyaid, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 300) with videos related to
Sort By:
Page
of 30
European Journal of Neurology
|
April 5, 2024
Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group
Michelangelo Mancuso, Maria T Papadopoulou, Yi Shiau Ng, et al.
BMC Cancer
|
June 20, 2020
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
David P French, Susan Astley, Adam R Brentnall, et al.
Trials
|
September 20, 2022
Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy
, Alaa Abouhajar, Lisa Alcock, et al.
Trials
|
October 5, 2022
Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy
, Alaa Abouhajar, Lisa Alcock, et al.
Brain Communications
|
December 5, 2025
Elevated glioma-related cortical glutamate <i>in vivo</i> is associated with <i>ex vivo</i> interictal discharges in human brain slices
Bodiabaduge Ashan P Jayasekera, Jehill Parikh, Tamara Modebadze, et al.
Scientific Reports
|
May 18, 2026
Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial
Renae J Stefanetti, Chiara Pizzamiglio, Alasdair P Blain, et al.
JAMA Neurology
|
April 11, 2017
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy
Ewen W Sommerville, Yi Shiau Ng, Charlotte L Alston, et al.
British Journal of Cancer
|
April 24, 2023
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
D Gareth Evans, Lorna McWilliams, Susan Astley, et al.
British Journal of Cancer
|
April 3, 2023
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
D Gareth Evans, Lorna McWilliams, Susan Astley, et al.
The Journal of Clinical Investigation
|
May 26, 2022
RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis
Jonathan Shintaku, Wolfgang M Pernice, Wafaa Eyaid, et al.
Page
of 30